Individuals Discontinuing Slimming Medications Gain Back Pounds Far More Rapidly Compared to Those on Conventional Diets

New research reveals that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who end conventional diet and exercise plans.

Findings released in a prominent medical journal shows that while overweight people frequently drop substantial amounts of their body weight while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.

"People purchasing these treatments need to be cognizant of the potential of rapid rebound weight gain when the medication is stopped," warns researcher Dr. Susan Jebb.

That rate of regain implies a return to original mass within about 18 months.

Analyzing Approaches

The analysis, which reviewed 37 of studies involving over 9,000 of participants, compared the effects of the injectable medications with older methods.

The team note that individuals who lose weight through dieting typically experience a slower weight regain—perhaps 100 grams monthly—post-intervention.

Understanding the Quick Rebound

Doctors propose the mechanism of the drugs is key to understanding the amplified weight return.

The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 concentrations far above than the body's typical production might result in the system to produce less of its own natural hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this hormone supplement results in hunger is no longer kept in check, making overeating far more likely."

A Lifelong Issue?

Health authorities suggest the jabs for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

A number of clinicians say that, due to the high risk of weight regain, the treatment is often life-long.

This opinion is reinforced by pharmaceutical companies, who state that the results "underscore the long-term nature of excess weight," similar to managing conditions like hypertension.

Patient Accounts

People who have stopped the jabs describe a intense resurgence of appetite.

"It felt as if something that goes on and you're instantly starving," described an individual.

The struggle is worsened if individuals have not adopted sustainable dietary or behavioural changes during therapy.

Growing Use

Figures suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with desire being substantial.

• Adoption is greater among females compared to men.
• The 40s and 50s age group shows the highest level of interest.
• Many access the medications through private healthcare rather than the NHS.

Finally, researchers stress that while the jabs are potent tools for shedding pounds, they are not a standalone cure and lasting health benefits hinges on combined behavioural changes.